HomeCompareNEWA vs KMB

NEWA vs KMB: Dividend Comparison 2026

NEWA yields 47.96% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NEWA wins by $308.5K in total portfolio value
10 years
NEWA
NEWA
● Live price
47.96%
Share price
$4.17
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$354.5K
Annual income
$69,481.25
Full NEWA calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.35
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,222.34
Full KMB calculator →

Portfolio growth — NEWA vs KMB

📍 NEWA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNEWAKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NEWA + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NEWA pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NEWA
Annual income on $10K today (after 15% tax)
$4,076.74/yr
After 10yr DRIP, annual income (after tax)
$59,059.06/yr
KMB
Annual income on $10K today (after 15% tax)
$446.39/yr
After 10yr DRIP, annual income (after tax)
$4,438.99/yr
At 15% tax rate, NEWA beats the other by $54,620.07/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NEWA + KMB for your $10,000?

NEWA: 50%KMB: 50%
100% KMB50/50100% NEWA
Portfolio after 10yr
$200.2K
Annual income
$37,351.79/yr
Blended yield
18.66%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

NEWA
No analyst data
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.7% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NEWA buys
0
KMB buys
0
No recent congressional trades found for NEWA or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNEWAKMB
Forward yield47.96%5.25%
Annual dividend / share$2.00$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17%
Portfolio after 10y$354.5K$45.9K
Annual income after 10y$69,481.25$5,222.34
Total dividends collected$280.0K$21.6K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: NEWA vs KMB ($10,000, DRIP)

YearNEWA PortfolioNEWA Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$15,496$4,796.16$11,314$614.45+$4.2KNEWA
2$23,527$6,945.99$12,867$760.19+$10.7KNEWA
3$35,030$9,855.78$14,713$945.27+$20.3KNEWA
4$51,196$13,714.41$16,924$1,181.90+$34.3KNEWA
5$73,512$18,732.47$19,596$1,486.64+$53.9KNEWA
6$103,796$25,138.22$22,850$1,882.16+$80.9KNEWA
7$144,234$33,172.11$26,849$2,399.80+$117.4KNEWA
8$197,411$43,079.99$31,812$3,083.36+$165.6KNEWA
9$266,335$55,105.38$38,033$3,994.72+$228.3KNEWA
10$354,459$69,481.25$45,918$5,222.34+$308.5KNEWA

NEWA vs KMB: Complete Analysis 2026

NEWAStock

Newater Technology, Inc. engages in the wastewater purification treatment solutions. The company is headquartered in Yantai, Shandong and currently employs 203 full-time employees. The firm is focused on the development, manufacture and sale of disk tube reverse osmosis (DTRO) and disk tube nanofiltration (DTNF) membrane filtration products that are used in the treatment, recycling and discharge of wastewater. The DTRO membrane and DTNF membrane is used to treat and recycle wastewater. The firm also supplies hardware and engineered systems necessary to implement integrated solutions with DTRO and DTNF products. The firm provides engineering support and installation, technical advice and service, and other project-related solutions to filter wastewater into clean water. The firm provides services to chemical and energy industries. The firm also offers traditional wastewater treatment solutions, such as activated carbon and resins.

Full NEWA Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this NEWA vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NEWA vs SCHDNEWA vs JEPINEWA vs ONEWA vs KONEWA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.